{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001103","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2024-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.270098+00:00","generated_at":"2026-06-07T04:06:18.724520+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"INBS regains Nasdaq compliance on stockholders' equity, but faces ongoing monitoring","bullets":["Nasdaq confirmed compliance with $2.5M min. equity requirement after INBS reported $4.24M equity as of Oct 31, 2023.","Equity increase primarily from public offering that closed Oct 4, 2023.","Nasdaq warned that failure to maintain compliance in next 10-Q (Dec 31, 2023) could lead to delisting.","Company still does not meet alternative listing standards (market value of $35M or net income of $500K)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001103","json":"https://secwatch.observer/filing/0001493152-24-001103.json","markdown":"https://secwatch.observer/filing/0001493152-24-001103.md","text":"https://secwatch.observer/filing/0001493152-24-001103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224001103/0001493152-24-001103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224001103/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:06:18.724520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd658865fb53bf38c727f1566f895daf90082a1b","claim":"INTELLIGENT BIO SOLUTIONS INC. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"January 2, 2024, to submit a plan to regain compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). On December 15, 2023, the Company submitted a compliance plan to Nasdaq that included a pro forma balance sheet as of October 31, 2023 (the “Balance Sheet”). The Balance Sheet showed that the Company’s stockholders’ equity as of October 31, 2023, was $4,240,629, which was primarily the result of the of a public offering of the Company’s securities that closed on October 4, 2023. The Balance Sheet was also attached to a Current Report on Form 8-K filed b","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725430/000149315224001103/0001493152-24-001103-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}